环氧化酶-2与乳腺癌关系的研究进展
出处
《中国妇幼保健》
CAS
北大核心
2008年第25期3631-3633,共3页
Maternal and Child Health Care of China
基金
吉林大学创新基金
项目号:419070202428
参考文献23
-
1Willoughby DA, Moore AR, Colville - Nash PR. COX - 1, COX - 2 and COX - 3 and the future treatment of chronic inflammatory disease. Lancet, 2000, 355 : 646 - 648.
-
2Cao Y, Pearman AT, Zimmerman GA et al. Intracellular unesterified arachidonic acid signals apoptosis. Proc Natl Acad Sci USA, 2000, 97 (21): 11280.
-
3Liu CH, Chang SH, Joarder FS et al. Overvxprvssion of cyclooxygenase -2 is sufficient to induce tumorigenesis in transgenic mice. J Biol Chem, 2001, 276 (21) : 18563.
-
4Howe LR, Chang SH, Tolle KC et al. HER2/neu - induced mammary tumorigenesis and angiogenesis are reduced in cyclooxygenase -2 knockout mice. Cancer Res, 2005, 65 (21) : 10113.
-
5Gilhooly EM, Rose DE The association between a mutated rats gene and cyclooxygenase - 2 expression in human breast cancer cell lines. Int J Oncol, 1999, 15 (2): 267.
-
6Ristimaki A, Sivula A, Lundin J et al. Prognostic significance of elevaluted cyclooxygenase - 2 expression in breast cancer. Cancer Ros, 2002, 62 (3) : 632.
-
7Surewlak P, Matema V, Matkowski R et al. Relationship between the expression of cyclooxygenase 2 and MDR1/P - glycopretein in invasive breast cancers and their prognostic significance. Breast Cancer Res, 2005, 7 (5): 862.
-
8Denkert C, Winzer KJ, Muller BM et al. Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast careinoma. Cancer, 2003, 97 (12) : 2978.
-
9Spizzo G, Gastl G, Wolf D et al. Correlation of COX -2 and Ep - CAM overexpression in human invasive breast cancer and its impact on survival. BrJ Cancer, 2003, 88 (4) : 574.
-
10Wulfing P, Diallo R. Analysis of cyclooxygenase -2 expression in human breast cancer: high throughout tissue microarray analysis. J Cancer Res Clin Oncol, 2003, 129 (7): 375.
二级参考文献32
-
1[4]Harris RE, Kasbari S, Farrar WB. Prospective study of nonsteroidal anti-inflammatory drugs and breast cancer [ J]. Oncol Rep, 1999, 6(1):71-73.
-
2[5]Harris RE, Alshafie GA, Abou Issa H, et al. Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase-2 inhibitor [J].Cancer Res, 2000, 60(8) :2101-2103.
-
3[6]Ristimaki A, Sivula A, Lundin J, et al. Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer [J].Cancer Res, 2002, 62(3):632-635.
-
4[7]DiGiovanna MP, Chu P, Davison TL, et al. Active signaling by HER-2/neu in a subpopulation of HER-2/neu-overexpressing ductal carcinoma in situ: clinicopathological correlates [J].Cancer Res, 2002, 62(22) :6667-6673.
-
5[8]Subbaramaiah K, Norton L, Gerald W, et al. Cyclooxygenase-2 is overexpressed in her-2/neu-positive breast cancer. Evidence for involvement of AP-1 and PEA3 [J]. J Biol Chem, 2002, 277(21): 18649- 18657.
-
6[1]Parrett ML, Harris RE, Joarder FS, et al. Cyclooxygenase-2 expression in human breast cancer [J]. Int J Oncol, 1997,10(6):503-507.
-
7[2]Eli Y, Przedecki F, Levin G, et al. Comparative effects of indomethacin on cell proliferation and cell cycle progression in tumor cells grown in vitro and in vivo [J]. Biochem Pharmacol, 2001,61(5):565-571.
-
8[3]Soslow RA, Dannenberg AJ, Rush D, et al. COX-2 is expressed in human pulmonary, colonic, and mammary tumors [J]. Cancer, 2000, 89(12):2637- 2645.
-
9Tsujii M, Kawano S, DuBois RN. Cyclooxygenases-2 expression in human colon cancer cells increases metastatic potential[J]. Proc Natl Acad Sic USA, 1997, 94 (7):3336-40.
-
10Soslow RA, Dannenberg AJ, Rush D, et al. COX-2 is expressed in human pulmonary, colonic, and mammary tumors[J]. Cancer, 2000, 89 (12) :2637-45.
共引文献54
-
1徐维华,汪立鑫.环氧合酶-2与乳腺癌的研究进展[J].中国现代药物应用,2009,3(3):180-181. 被引量:1
-
2吴平,陈念平,黄冰,何惠娟,杨展.环氧化酶-2基因和蛋白在人胃癌组织中的表达及临床意义[J].中国肿瘤临床,2004,31(15):860-863. 被引量:6
-
3郭贵龙,姚榛祥.环氧化酶-2在人乳腺癌中的表达及对肿瘤血管形成的影响[J].中华外科杂志,2004,42(20):1271-1272. 被引量:18
-
4宋伟庆,韩彩丽,周保军,张轶华,陈怡,刘玉,韦金英.COX-2与hMLH1、hMSH2在大肠癌中表达的相关性研究[J].世界华人消化杂志,2005,13(1):105-109. 被引量:6
-
5郭贵龙,张筱骅,姚榛祥.环氧化酶-2抑制剂nimesulide对乳腺癌细胞株增生、凋亡的影响[J].肿瘤研究与临床,2005,17(1):6-9. 被引量:1
-
6郭贵龙,姚榛祥.环氧化酶-2与乳腺癌的研究进展[J].山西医科大学学报,2005,36(3):381-383.
-
7周世权,施小六,陈森林,莫烨,王永俊,李陈婕,宁文峰,姚茂金,汪斐.β-catenin和COX-2在大肠癌中的表达及临床意义[J].中国医师杂志,2005,7(7):889-891. 被引量:5
-
8郭贵龙,张筱骅,姚榛祥.尼美舒利对二甲基苯并蒽诱导的乳腺癌的影响及机制的实验研究[J].中华外科杂志,2005,43(15):1017-1020. 被引量:4
-
9郭贵龙,李卓英,周素梅,金纯,林包荣,张筱骅.环氧化酶-2在人、大鼠乳腺癌及人乳腺癌细胞株的表达及其意义[J].肿瘤研究与临床,2006,18(5):292-295. 被引量:6
-
10虞长春,吴强,吴正升,凌晓光,杨枫.肝细胞肝癌中COX-2表达与Survivin和Caspase-3的关系[J].安徽医科大学学报,2006,41(4):399-401. 被引量:5
-
1周慧聪,李继昌.环氧合酶-2致癌机制研究进展[J].河南肿瘤学杂志,2004,17(1):69-71. 被引量:5
-
2陆志城.环氧化酶及其研究进展[J].广东药学,2004,14(3):65-69. 被引量:6
-
3施文,王永铭.环氧酶(COX)家族的生物学研究进展[J].中国药学杂志,2004,39(4):246-249. 被引量:11
-
4刘敏.BYU与Merck公司达成COX—3转让协议[J].国外药讯,2003(5):35-35.
-
5苏县辉.对乙酰氨基酚作用机制的新学说[J].国外医学(药学分册),2006,33(2):157-157. 被引量:7
-
6康星欣,蒋世云,徐丹,魏娜.环氧合酶3在抗炎方面的研究[J].山东化工,2016,45(6):33-37. 被引量:4
-
7高砚春,吴诚义.环氧化酶-2与肿瘤关系的研究进展[J].川北医学院学报,2010,25(1):88-91. 被引量:2
-
8解热镇痛、抗炎、抗风湿药[J].健康必读(乡村医生),2011(8):48-49.
-
9张海港,李晓辉.环氧酶——研究与展望[J].中国药理通讯,2003,20(2):53-53. 被引量:1
-
10贾云.环氧化酶-2与胆囊癌关系研究[J].中国中医药咨讯,2010(28):85-85.